GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Lombard Medical Technologies PLC (LSE:LMT) » Definitions » Capital Expenditure

Lombard Medical Technologies (LSE:LMT) Capital Expenditure : £-0.14 Mil (TTM As of Dec. 2012)


View and export this data going back to . Start your Free Trial

What is Lombard Medical Technologies Capital Expenditure?

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Lombard Medical Technologies's cash flow for capital expenditures for the six months ended in Dec. 2012 was £-0.14 Mil. Its cash flow for capital expenditures for the trailing twelve months (TTM) ended in Dec. 2012 was £-0.14 Mil.

Lombard Medical Technologies Capital Expenditure Historical Data

The historical data trend for Lombard Medical Technologies's Capital Expenditure can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lombard Medical Technologies Capital Expenditure Chart

Lombard Medical Technologies Annual Data
Trend Sep02 Dec04 Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12
Capital Expenditure
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.21 -0.02 -0.10 -0.53 -0.14

Lombard Medical Technologies Semi-Annual Data
Sep02 Dec04 Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12
Capital Expenditure Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.21 -0.02 -0.10 -0.53 -0.14

Lombard Medical Technologies Capital Expenditure Calculation

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Capital Expenditure for the trailing twelve months (TTM) ended in Dec. 2012 was £-0.14 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lombard Medical Technologies (LSE:LMT) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Lombard Medical Technologies PLC (LSE:LMT) » Definitions » Capital Expenditure
Comparable Companies
XKLS:2127 HBIO XKRX:179290 UGHL ROCO:6612 ROCO:4150 XKRX:049180 HKSE:00876 OHEL:SILMA OSTO:ELOS B ISX:MARK IGAP XPAR:AMPLI ROCO:5312 BKK:TOG HKSE:01120 SSKN TSE:7775 ROCO:6499 OSTO:QLINEA
Traded in Other Exchanges
N/A
Address
Website
http://www.lombardmedical.com
Lombard Medical Technologies PLC is engaged in the design and development of endovascular stent grafts, their manufacture, and commercialization either directly through the group's own sales force or through a network of local distributors supported by clinical specialists from Lombard Medical. The principal product, the AorfixT AAA stent graft has European CE mark approval for use in patients with high-angle-neck aneurysms of up to 90 degrees. The group has operations in United Kingdom and United States of America.